Company news

TELA Bio, Inc. news in 2025

TELA Bio, Inc.'s news releases, calls and decks from 2025, newest first.

View company

TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference

November 19, 2025

TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants

November 13, 2025

TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility

November 13, 2025

TELA Bio to Announce Third Quarter 2025 Financial Results

November 4, 2025

TELA Bio Appoints William Plovanic to Board of Directors

November 3, 2025

TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran

October 9, 2025

TELA Bio Reports Second Quarter 2025 Financial Results

August 11, 2025

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference

July 23, 2025

TELA Bio to Announce Second Quarter 2025 Financial Results

July 21, 2025

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 6, 2025

TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair

June 3, 2025

TELA Bio Appoints Jeffrey Blizard as President

June 2, 2025

TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference

May 22, 2025

TELA Bio Reports First Quarter 2025 Financial Results

May 8, 2025

TELA Bio to Announce First Quarter 2025 Financial Results

April 17, 2025

TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery

March 31, 2025

TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results

March 20, 2025

TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results

February 27, 2025

Calls in 2025

Decks in 2025